CF PharmTech (02652) Announces Share Repurchase and Updated Shareholdings

Bulletin Express19:21

CF PharmTech, Inc. (02652) disclosed that on 27 February 2026, the company repurchased 30,500 of its H shares at a volume-weighted average price of HKD 38.69 per share. This transaction involved a total spending of HKD 1.18 million and represented 0.0101% of the company’s previously issued ordinary shares.

Following the repurchase, the number of issued shares excluding treasury shares stands at 301,727,086, while treasury shares amount to 496,500. The total number of shares of CF PharmTech remains 302,223,586. The mandate to conduct such repurchases was granted on 16 December 2025, with total authorized repurchases of up to 30,222,358 shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment